arrow_back Back to App

Lower Costs for Inhalers and Nebulizers for Patients

This act aims to reduce the cost of prescription inhaler products and related equipment for breathing disorders like asthma and COPD. It caps patient cost-sharing at $15 per 30-day supply and eliminates deductibles, making essential treatments more accessible.
Key points
Patient cost-sharing for a 30-day supply of specified inhaler products will not exceed $15.
Health plans cannot apply deductibles to specified inhaler products.
These changes will apply to private insurance, Medicare (Parts B and D), and programs for uninsured individuals, effective January 1, 2026.
Cost-sharing amounts will count towards out-of-pocket maximums.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5278
Sponsor: Rep. Mfume, Kweisi [D-MD-7]
Process start date: 2025-09-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Affordable Inhalers and Nebulizers Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5278.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-10.

What are the main provisions?

Key points include:

  • Patient cost-sharing for a 30-day supply of specified inhaler products will not exceed $15.
  • Health plans cannot apply deductibles to specified inhaler products.
  • These changes will apply to private insurance, Medicare (Parts B and D), and programs for uninsured individuals, effective January 1, 2026.
  • Cost-sharing amounts will count towards out-of-pocket maximums.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Mfume, Kweisi [D-MD-7].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health